Randomized Controlled Trial of Videoconference delivered Cognitive Behavioral Therapy for Adults with Attention Deficit/Hyperactivity Disorder

Randomized Controlled Trial of Videoconference delivered Cognitive Behavioral Therapy for Adults with Attention Deficit/Hyperactivity Disorder - Randomized Controlled Trial of Videoconference delivered Cognitive Behavioral Therapy for Adults with Attention Deficit/Hyperactivity Disorder

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000048009

Enrollment

Registered

2022-06-09

Start date

2022-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit/Hyperactivity Disorder

Interventions

Video-conference based cognitive behavioral therapy for ADHD(12weeks) Wait-list control (12weeks)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Patients who meet the diagnostic criteria in the DSM-5 based on the CAADID (Conners' Adult ADHD Diagnostic Interview for DSM-IV). (2)Male or Female, aged 18-65 years (3) Patients is willing and able to give informed consent for participation in the study. (4)Able to communicate fluently and participate cognitive behavioral therapy sessions in Japanese (5)Patients with regular medical care for A D H D at least once every 8 weeks (6)Patients who have been stabilized on medications for ADHD (7) Able to use the Internet and computer

Exclusion criteria

Exclusion criteria: (1) Diagnosis of schizophrenia, conduct disorders, organic disorder, mental retardation, neurocognitive disorder (dementia), autistic spectrum disorder, or substance abuse/substance dependence disorder (2) Active suicidal ideation (3) Unable to communicate fluently in Japanese. (4) Patients who have received cognitive behavioral therapy in the past (5) Other reasons inadequate for study participation

Design outcomes

Primary

Measure	Time frame
the ADHD-RS-IV with Adult Prompts Japanese Version Pre test Post test	—

Secondary

Measure	Time frame
Conners' Adult ADHD Rating Scale ADHD Symptoms Checklist Patient Health Questionnaire-9 (PHQ-9) Generalized Anxiety Disorder-7 (GAD-7) Euro Qol 5 Dimension 5 level (EQ-5D-5L) Sheehan Disability Scale(SDISS) Rosenberg's Self-esteem Scale Pre test Post test	—

Countries

Japan

Contacts

Public ContactAiko Eto

Graduate School of Medicine Chiba University Department of Cognitive Behavioral Physiology

21fd0129@student.gs.chiba-u.jp043-226-2027

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026